HAL vs TRVI · P/E 9.3, $19.05B cap vs $2.32B cap
Halliburton Company (HAL) versus Trevi Therapeutics Inc (TRVI) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
TRVI does not have a complete income-statement cache yet.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. TRVI currently screens at market cap $2.32B.
Not investment advice. Open the HAL and TRVI stock pages for the full models.
Not investment advice.